Related Experiment Video

Updated: Aug 7, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Cystatin C, kidney function and cardiovascular disease

Arend Bökenkamp, Stefan Herget-Rosenthal, Regina Bökenkamp

    Pediatric Nephrology (Berlin, Germany)
    |July 14, 2006
    PubMed

    Insights

    Serum cystatin C levels, a marker for kidney function, are linked to cardiovascular disease risk and inflammation. Microinflammation may unify these associations, suggesting early chronic kidney dysfunction.

    Area of Science:

    • Biochemistry
    • Nephrology
    • Cardiology

    Background:

    • Cystatin C, a glomerular filtration rate marker, correlates with cardiovascular disease and early chronic kidney dysfunction.
    • Local cystatin C deficiency in atherosclerotic lesions suggests a protective vascular role, potentially involving TGF-beta1.

    Discussion:

    • Serum cystatin C elevation is significantly associated with increased C-reactive protein (CRP), indicating a link to chronic inflammation.
    • The widespread production of cystatin C suggests systemic factors, not local synthesis, primarily influence serum concentrations.

    Key Insights:

    • Microinflammation is proposed as a unifying concept linking cystatin C levels to both renal dysfunction and vascular disease.
    • Cystatin C may serve as an early indicator of subclinical renal impairment and associated cardiovascular risk.

    Outlook:

    • Further research into the role of microinflammation in cystatin C metabolism and cardiovascular outcomes is warranted.
    • Investigating cystatin C as a biomarker for early detection and management of chronic kidney disease and atherosclerosis is crucial.

    Related Concept Videos

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...
    Urinary Tract Calculi I: Introduction01:28

    Urinary Tract Calculi I: Introduction

    Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
    Chronic Kidney Disease I: Introduction01:25

    Chronic Kidney Disease I: Introduction

    Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
    Chronic Kidney Disease III: Interprofessional Care01:28

    Chronic Kidney Disease III: Interprofessional Care

    Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
    Chronic Kidney Disease II: Clinical Manifestations01:24

    Chronic Kidney Disease II: Clinical Manifestations

    Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
    Renal Corpuscle01:20

    Renal Corpuscle

    The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
    Glomerulus: Structure and Function
    The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...